Disparities in clinical trial participation in ovarian cancer: A real-world analysis

•In a national cohort of 7540 patients with ovarian cancer, only 5.0% ever participated in a clinical drug trial.•Hispanic or Latino patients were 71% less likely to participate in ovarian cancer clinical trials.•Patients with Medicaid were 51% less likely and patients with Medicare 32% less likely to participate in clinical trials than privately-insured patients.